Polymorphisms at position 245 of HIV reverse transcriptase do not accurately predict the presence of human leukocyte antigen B*5701.
Waters
Laura J
LJ
Mackie
Nicola E
NE
Pozniak
Anton
A
Winston
Alan
A
D000483:Alleles; D019380:Anti-HIV Agents / Q000009:adverse effects; D015331:Cohort Studies; D015224:Dideoxynucleosides / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000453:epidemiology / Q000517:prevention & control; D005819:Genetic Markers; D005820:Genetic Testing / Q000379:methods*; D054303:HIV Reverse Transcriptase / Q000235:genetics*; D015235:HLA-B Antigens / Q000235:genetics*; D006801:Humans; D015994:Incidence; D011110:Polymorphism, Genetic; D012680:Sensitivity and Specificity; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D005819:Genetic Markers; D054303:HIV Reverse Transcriptase; D015235:HLA-B Antigens; D000099227:Abacavir; C484830:HLA-B*57:01 antigen